Bayer Lowers FY2026 Adj EPS Guidance from $1.25-$1.40 to $1.20-$1.35 vs $1.20 Est; Lowers FY2026 Sales Guidance from $52.387B-$54.715B to $52.109B-$54.451B vs $53.200B Est

Benzinga Newsdesk www.benzinga.com Negative 95.5%

Neg 95.5% Neu 0% Pos 0%

Bayer (OTC:BAYRY) lowers FY2026 Adj EPS guidance from $1.25-$1.40 to $1.20-$1.35 vs $1.20 analyst estimate. Lowers FY2026 sales outlook from $52.387 billion-$54.715 billion to $52.109 billion-$54.451 billion vs $53.200 billion estimate.